| Chapter: 1 (Page no: 1)
|
Principles of antimicrobial stewardship.
Author(s):
Cunha, C. B.
|
| Chapter: 2 (Page no: 8)
|
Clinical perspectives on antimicrobial stewardship.
Author(s):
Styliani Karanika
Suresh Paudel
Mylonakis, E.
|
| Chapter: 3 (Page no: 15)
|
History of antimicrobial stewardship.
Author(s):
Kazanjian, P.
|
| Chapter: 4 (Page no: 24)
|
The importance of education in antimicrobial stewardship.
Author(s):
Gyssens, I. C.
|
| Chapter: 5 (Page no: 39)
|
Mechanisms of resistance to antibacterial agents.
Author(s):
Rice, L. B.
|
| Chapter: 6 (Page no: 53)
|
Antimicrobial resistance: selection vs. induction.
Author(s):
Araos, R.
Munita, J. M.
Arias, C. A.
|
| Chapter: 7 (Page no: 68)
|
Colonization and its importance for the emergence of clinical resistance.
Author(s):
Donskey, C. J.
|
| Chapter: 8 (Page no: 80)
|
Antibiotic resistance: associations and implications for antibiotic usage strategies to control multiresistant bacteria.
Author(s):
Rice, L. B.
|
| Chapter: 9 (Page no: 94)
|
The role of active surveillance in the prevention of healthcare-acquired infections and antibiotic stewardship.
Author(s):
Capraro, G. A.
|
| Chapter: 10 (Page no: 104)
|
The role of the antibiogram in antibiotic stewardship.
Author(s):
Doern, G. V.
|
| Chapter: 11 (Page no: 110)
|
Selective reporting and antimicrobial stewardship.
Author(s):
Doern, C. D.
Burnham, C. A. D.
|
| Chapter: 12 (Page no: 124)
|
The role of new diagnostics to enhance antibiotic stewardship efforts.
Author(s):
Chapin, K. C.
Bobenchik, A. M.
|
| Chapter: 13 (Page no: 137)
|
Epidemiology of Staphylococcus aureus and enterococci and an overview of antimicrobial resistance.
Author(s):
Bartlett, A. H.
Daum, R. S.
|
| Chapter: 14 (Page no: 152)
|
Epidemiology of multidrug-resistant Gram-negative organisms.
Author(s):
Piperaki, E. T.
Markogiannakis, A.
Tzouvelekis, L.
Daikos, G. L.
|
| Chapter: 15 (Page no: 163)
|
Pathogenesis and epidemiology of Clostridium difficile infection: implications for antibiotic stewardship.
Author(s):
Gonzalez, B. E.
Toltzis, P.
|
| Chapter: 16 (Page no: 175)
|
The role of the hospital epidemiologist in supporting antimicrobial stewardship.
Author(s):
Calderwood, M. S.
|
| Chapter: 17 (Page no: 179)
|
Principles of pharmacokinetic/pharmacodynamic optimization for antibiotic dosing.
Author(s):
Ghazi, I. M.
Kuti, J. L.
Nicolau, D. P.
|
| Chapter: 18 (Page no: 196)
|
Optimal use of Gram-negative antibiotics in the real world: providing effective therapy while minimizing resistance.
Author(s):
Pogue, J. M.
Ortwine, J. K.
Kaye, K. S.
|
| Chapter: 19 (Page no: 209)
|
Optimal use of fluoroquinolones.
Author(s):
Dilworth, T. J.
Elshaboury, R. H.
Rotschafer, J. C.
|
| Chapter: 20 (Page no: 224)
|
Optimal use of β-lactam antibiotics.
Author(s):
Rose, W.
Berti, A.
|
| Chapter: 21 (Page no: 235)
|
Current approach to optimal use and dosing of vancomycin in adult patients.
Author(s):
Carreno, J. J.
Martirosov, D.
Lodise, T. P.
|
| Chapter: 22 (Page no: 255)
|
Principles of switching from intravenous to oral administration.
Author(s):
Wagner, J. L.
Davis, S. L.
|
| Chapter: 23 (Page no: 266)
|
The role of pharmacists in antimicrobial stewardship.
Author(s):
Morrill, H. J.
Dorobisz, M.
LaPlante, K. L.
|
| Chapter: 24 (Page no: 276)
|
Formulary management and economic considerations: bridging the gap between quality care and cost.
Author(s):
McManus, D.
Ruggero, M. A.
Topal, J. E.
|
| Chapter: 25 (Page no: 284)
|
Approaches to benchmarking antibiotic use.
Author(s):
Heil, E. L.
Standiford, H. C.
|
| Chapter: 26 (Page no: 290)
|
Development and execution of stewardship interventions.
Author(s):
Hanson, A.
Crank, C. W.
|
| Chapter: 27 (Page no: 302)
|
Technologic support for antimicrobial stewardship.
Author(s):
Mercier, R. C.
Walraven, C.
|
| Chapter: 28 (Page no: 315)
|
Role of guidelines and statistical milestones for antimicrobial stewardship.
Author(s):
Torres, D. C.
|
| Chapter: 29 (Page no: 322)
|
Economic considerations of antimicrobial stewardship programs.
Author(s):
Ziakas, P. D.
|
| Chapter: 30 (Page no: 334)
|
Pharmacoeconomic implications of antimicrobial adverse events.
Author(s):
Cunha, C. B.
|
| Chapter: 31 (Page no: 342)
|
Antimicrobial stewardship programs in areas of increased pathogen resistance.
Author(s):
Samarkos, M.
Sipsas, N. V.
|
| Chapter: 32 (Page no: 352)
|
Role of antimicrobial stewardship in pediatrics.
Author(s):
Goldman, J. L.
Newland, J. G.
|
| Chapter: 33 (Page no: 363)
|
Antimicrobial stewardship in the intensive care unit.
Author(s):
Tadele, M.
Boothe, H. G.
Stone, M. E., Jr.
McNelis, J.
|
| Chapter: 34 (Page no: 376)
|
Role of antimicrobial stewardship in a community hospital.
Author(s):
Estrada, S. J.
Martinez, A.
|
| Chapter: 35 (Page no: 384)
|
Outpatient parenteral antimicrobial therapy.
Author(s):
Graber, C. J.
Armen Arshakyan
|
| Chapter: 36 (Page no: 391)
|
Importance of interdisciplinary collaboration in antimicrobial stewardship: immersion of future healthcare professionals.
Author(s):
Morton, J.
LaPlante, K. L.
|
| Chapter: 38 (Page no: 412)
|
A hospitalist perspective on the role of antimicrobial stewardship.
Author(s):
Sajeev Handa
|